Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 858567916 | 8585679 | 16 | F | 20120326 | 20160909 | 20120530 | 20160914 | EXP | US-GLAXOSMITHKLINE-A0972199A | GLAXOSMITHKLINE | 55.65 | YR | F | Y | 51.00000 | KG | 20160914 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 858567916 | 8585679 | 1 | PS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 19 NG/KG/MIN CONTINUOUSLYCONCENTRATION: 30,000 NG/MLPUMP RATE NOT REPORTEDVIAL STRENGTH 1.5MG | U | N145 | 20444 | 19 | DF | POWDER FOR INFUSION | |||||
| 858567916 | 8585679 | 2 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | N513 | 20444 | POWDER FOR INFUSION | ||||||||
| 858567916 | 8585679 | 3 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | R201A | 20444 | POWDER FOR INFUSION | ||||||||
| 858567916 | 8585679 | 4 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | P057 | 20444 | POWDER FOR INFUSION | ||||||||
| 858567916 | 8585679 | 5 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | S925 | 20444 | POWDER FOR INFUSION | ||||||||
| 858567916 | 8585679 | 6 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | 20444 | POWDER FOR INFUSION | |||||||||
| 858567916 | 8585679 | 7 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 19 DF, CO | U | T366 | 20444 | 19 | DF | POWDER FOR INFUSION | |||||
| 858567916 | 8585679 | 8 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 19 NG/KG/MIN, CO | U | T794 | 20444 | POWDER FOR INFUSION | ||||||||
| 858567916 | 8585679 | 9 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK, CO | U | V049 | 20444 | POWDER FOR INFUSION | ||||||||
| 858567916 | 8585679 | 10 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK, CO | U | V049 | 20444 | POWDER FOR INFUSION | ||||||||
| 858567916 | 8585679 | 11 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 19 NG/KG/MIN, CO | U | Z111 | 20444 | POWDER FOR INFUSION | ||||||||
| 858567916 | 8585679 | 12 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 19 NG/KG/MIN CONTINUOUS | U | Z606 | 20444 | 19 | DF | POWDER FOR INFUSION | |||||
| 858567916 | 8585679 | 13 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | 0 | SOLUTION FOR INJECTION | |||||||||
| 858567916 | 8585679 | 14 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 19 NG/KG/MIN (CONCENTRATION 30,000 NG/ML, PUMP RATE 54 ML/DAY, VIAL STRENGTH 1.5 MG), CO | U | C764454 | 0 | SOLUTION FOR INJECTION | ||||||||
| 858567916 | 8585679 | 15 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 19 NG/KG/MIN (CONCENTRATION 30,000 NG/ML, PUMP RATE 54 ML/DAY, VIAL STRENGTH 1.5 MG), CO | U | Z880 | 0 | SOLUTION FOR INJECTION | ||||||||
| 858567916 | 8585679 | 16 | SS | VELETRI | EPOPROSTENOL | 1 | Intravenous (not otherwise specified) | U | 20444 | 19 | DF | ||||||||
| 858567916 | 8585679 | 17 | C | REVATIO | SILDENAFIL CITRATE | 1 | U | 0 | 20 | MG | TID | ||||||||
| 858567916 | 8585679 | 18 | C | COUMADIN | WARFARIN SODIUM | 1 | U | 0 | |||||||||||
| 858567916 | 8585679 | 19 | C | ADEMPAS | RIOCIGUAT | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 858567916 | 8585679 | 1 | Cor pulmonale chronic |
| 858567916 | 8585679 | 2 | Pulmonary hypertension |
| 858567916 | 8585679 | 13 | Cor pulmonale chronic |
| 858567916 | 8585679 | 14 | Pulmonary hypertension |
| 858567916 | 8585679 | 16 | Cor pulmonale chronic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 858567916 | 8585679 | HO |
| 858567916 | 8585679 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 858567916 | 8585679 | Bacterial infection | |
| 858567916 | 8585679 | Cardiac disorder | |
| 858567916 | 8585679 | Cardiac operation | |
| 858567916 | 8585679 | Catheter site erythema | |
| 858567916 | 8585679 | Catheter site infection | |
| 858567916 | 8585679 | Cough | |
| 858567916 | 8585679 | Cyst aspiration | |
| 858567916 | 8585679 | Device connection issue | |
| 858567916 | 8585679 | Device related infection | |
| 858567916 | 8585679 | Diarrhoea | |
| 858567916 | 8585679 | Endoscopy | |
| 858567916 | 8585679 | Headache | |
| 858567916 | 8585679 | Influenza | |
| 858567916 | 8585679 | Malaise | |
| 858567916 | 8585679 | Nasopharyngitis | |
| 858567916 | 8585679 | Pain in extremity | |
| 858567916 | 8585679 | Pain in jaw |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 858567916 | 8585679 | 1 | 19990106 | 0 | ||
| 858567916 | 8585679 | 2 | 19990106 | 0 | ||
| 858567916 | 8585679 | 3 | 19990106 | 0 | ||
| 858567916 | 8585679 | 4 | 19990106 | 0 | ||
| 858567916 | 8585679 | 7 | 19990604 | 0 | ||
| 858567916 | 8585679 | 9 | 20131028 | 0 | ||
| 858567916 | 8585679 | 10 | 20131028 | 0 | ||
| 858567916 | 8585679 | 11 | 20131028 | 0 | ||
| 858567916 | 8585679 | 12 | 20131028 | 0 | ||
| 858567916 | 8585679 | 13 | 20131028 | 0 | ||
| 858567916 | 8585679 | 14 | 20131028 | 0 | ||
| 858567916 | 8585679 | 15 | 20131028 | 0 | ||
| 858567916 | 8585679 | 16 | 20130703 | 0 |